Article in Current opinion in virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
2 authors.
Margo A BrintonDepartment of Biology, Petit Science Center Rm 623, 100 Piedmont Ave SE, Atlanta, GA 30303, United States. Electronic address: mbrinton@gsu.edu.
Richard K PlemperInstitute for Biomedical Sciences, Petit Science Center Rm 712, 100 Piedmont Ave SE, Atlanta, GA 30303, United States. Electronic address: rplemper@gsu.edu.
Funding
Identification and Pre-Clinical Evaluation of Measles Virus InhibitorsR01AI071002 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2006 to 2022
$6.6M
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza VirusesR01AI141222 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2019 to 2023
$5.0M
Functional analysis of flavivirus genetic resistance.R01AI045135 · NIAID · GEORGIA STATE UNIVERSITY · PI BRINTON, MARGO A, KAUR, PARJIT · 2000 to 2018
$4.8M
Novel Therapeutics against Respiratory Syncytial Virus InfectionR01HD079327 · NICHD · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2014 to 2018
$2.8M
Regulation of West Nile Virus ReplicationR01AI048088 · NIAID · GEORGIA STATE UNIVERSITY · PI BRINTON, MARGO A · 2003 to 2012
$2.3M
Drug discovery against lyssaviruses by high thoughput screeningR01AI127823 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI PLEMPER, RICHARD K., SCHNELL, MATTHIAS JOHANNES · 2017 to 2019
$1.2M
Oas-1 gene transgenic mice for WNV research.R21AI059187 · NIAID · GEORGIA STATE UNIVERSITY · PI BRINTON, MARGO A · 2004 to 2005
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses. · full record | OpenQuestion